1. Anticyclic citrullinated peptide antibody-negative rheumatoid arthritis: Clues to disease pathogenesis

   • Mary K. Crow

   Invited Commentary 24 October 2008 Pages: 165 - 167

2. Web alert

   OriginalPaper 24 October 2008 Pages: 168 - 169

3. In perspective: Murine models of scleroderma

   • Minghua Wu
   • John Varga

   OriginalPaper 24 October 2008 Pages: 173 - 182

4. Circulating progenitor cells and scleroderma

   • Richard H. Gomer

   OriginalPaper 24 October 2008 Pages: 183 - 188

5. Cellular therapy of systemic sclerosis

   • Jacob M. van Laar
   • Alan Tyndall

   OriginalPaper 24 October 2008 Pages: 189 - 194

6. Nephrogenic systemic fibrosis: An epidemic of gadolinium toxicity

   • Derrick J. Todd
   • Jonathan Kay

   OriginalPaper 24 October 2008 Pages: 195 - 204

7. Scleroderma gene expression and pathway signatures

   • Jennifer L. Sargent
   • Ausra Milano
   • Michael L. Whitfield

   OriginalPaper 24 October 2008 Pages: 205 - 211

8. Clinical trials report

   • Robert Terkeltaub

   Report 24 October 2008 Pages: 215 - 217

9. Colchicine: Its mechanism of action and efficacy in crystal-induced inflammation

   • George Nuki

   OriginalPaper 24 October 2008 Pages: 218 - 227

10. Treating difficult crystal pyrophosphate dihydrate deposition disease

    • Nadia Announ
    • Pierre-André Guerne

    OriginalPaper 24 October 2008 Pages: 228 - 234

11. Non-crystalline and crystalline rheumatic disorders in chronic kidney disease

    • Pasha Sarraf
    • Jonathan Kay
    • Anthony M. Reginato

    OriginalPaper 24 October 2008 Pages: 235 - 248

12. Gout and coronary artery disease: Epidemiologic clues

    • Eswar Krishnan

    OriginalPaper 24 October 2008 Pages: 249 - 255